STOCK TITAN

If You Invested in G1 Therapeutics, Inc. (GTHX)

Pharmaceutical Preparations · NASDAQ
Looking for the current price? See the GTHX quote & overview
$1,000 invested 1 Year Ago
N/A
Trading since 2017-05-17
$1,000 invested 5 Years Ago
$471
-52.9% price return -23.0% CAGR
-52.9% with dividends reinvested
Bought on Nov 1, 2021 at $15.17 split-adjusted
$1,000 invested 10 Years Ago
N/A
Trading since 2017-05-17

What $1,000 or $10,000 in GTHX Would Be Worth Now

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since May 17, 2017
$1,000 — $471 -53% — $477 -52%
$10,000 — $4,713 -53% — $4,767 -52%

Based on real historical closing prices adjusted for stock splits, without dividends, through 2024-09-17. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for GTHX

$1,000 Investment Over Time

GTHX vs S&P 500

Year-by-Year Returns

GTHX annual performance
Year Start Price End Price Annual Return Cumulative
2017 $15.00 $19.84 +32.3% +32.3%
2018 $19.84 $19.15 -3.5% +27.7%
2019 $19.15 $26.43 +38.0% +76.2%
2020 $26.43 $17.99 -31.9% +19.9%
2021 $17.99 $10.21 -43.2% -31.9%
2022 $10.21 $5.43 -46.8% -63.8%
2023 $5.43 $3.05 -43.8% -79.7%
2024 $3.05 $7.15 +134.4% -52.3%

About G1 Therapeutics, Inc.

NASDAQ

Current Price
$7.15
View full GTHX overview

Frequently Asked Questions

G1 Therapeutics, Inc. investment returns

How much would $1,000 invested in G1 Therapeutics, Inc. be worth today?

If you invested $1,000 in G1 Therapeutics, Inc. (GTHX) 5 years ago on 2021-11-01, your investment would be worth $471 as of 2024-09-17, a -52.9% price return without dividends, growing at a compounded rate of -23.0% per year (CAGR).

Has G1 Therapeutics, Inc. outperformed the S&P 500?

Comparison data requires at least 10 years of trading history. Use the calculator above to compare GTHX performance over available time periods.

What is G1 Therapeutics, Inc.'s average annual return?

The compound annual growth rate (CAGR) of GTHX’s share price over the past 5 years is -23.0%, without dividends. Individual years vary a great deal, and GTHX’s best recent full year was 2019 (+38.0%) while the worst was 2022 (-46.8%).

For informational and educational purposes only, not investment advice.